Podcast on the Management of Adverse Events Associated with Lorlatinib

por Bauer, Todd M., Bertino, Erin M.
Publicado 2022

Advances in epigenetic therapeutics with focus on solid tumors

por Jin, Ning, George, Tiffany L., Otterson, Gregory A., Verschraegen, Claire, Wen, Haitao, Carbone, David, Herman, James, Bertino, Erin M., He, Kai
Publicado 2021

Too Many Appointments: Assessing Provider and Nursing Perception of Barriers to Referral for Outpatient Palliative Care

por Agne, Julia L., Bertino, Erin M., Grogan, Madison, Benedict, Jason, Janse, Sarah, Naughton, Michelle, Eastep, Christine, Callahan, Michael, Presley, Carolyn J.
Publicado 2021

Impact of an Embedded Palliative Care Clinic on Healthcare Utilization for Patients With a New Thoracic Malignancy

por Gast, Kelly C., Benedict, Jason A., Grogan, Madison, Janse, Sarah, Saphire, Maureen, Kumar, Pooja, Bertino, Erin M., Agne, Julia L., Presley, Carolyn J.
Publicado 2022

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With None–Small-cell Lung Cancer

por Owen, Dwight H., Wei, Lai, Bertino, Erin M., Edd, Thomas, Villalona-Calero, Miguel A., He, Kai, Shields, Peter G., Carbone, David P., Otterson, Gregory A.
Publicado 2018

Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancy

por Bertino, Erin M., Grogan, Madison M., Benedict, Jason A., Agne, Julia L., Janse, Sarah, Eastep, Christine, Sullivan, Diana, Gast, Kelly C., Naughton, Michelle J., Presley, Carolyn J.
Publicado 2023

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database

por Miller, Eric D, Fisher, James L, Haglund, Karl E, Grecula, John C, Xu-Welliver, Meng, Bertino, Erin M, He, Kai, Shields, Peter G, Carbone, David P, Williams, Terence M, Otterson, Gregory A, Bazan, Jose G
Publicado 2018

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

por Li, Mingjia, Spakowicz, Daniel, Burkart, Jarred, Patel, Sandip, Husain, Marium, He, Kai, Bertino, Erin M., Shields, Peter G., Carbone, David P., Verschraegen, Claire F., Presley, Carolyn J., Otterson, Gregory A., Kendra, Kari, Owen, Dwight H.
Publicado 2019

Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors

por Bond, David A, Huang, Ying, Fisher, James L, Ruppert, Amy S, Owen, Dwight H, Bertino, Erin M, Rogers, Kerry A, Bhat, Seema A, Grever, Michael R, Jaglowski, Samantha M, Maddocks, Kami J, Byrd, John C, Woyach, Jennifer A
Publicado 2020

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

por Haddad, Tyler C., Zhao, Songzhu, Li, Mingjia, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Lopez, Gabriella, Miah, Abdul, Wei, Lai, Tinoco, Gabriel, Riesenberg, Brian, Li, Zihai, Meara, Alexa, Bertino, Erin M., Kendra, Kari, Otterson, Gregory, Presley, Carolyn J., Owen, Dwight H.
Publicado 2021